The Combined CTA1-DD/ISCOM Adjuvant Vector Promotes Priming of Mucosal and Systemic Immunity to Incorporated Antigens by Specific Targeting of B Cells-Reference-Cited by-同舟云学术

The Combined CTA1-DD/ISCOM Adjuvant Vector Promotes Priming of Mucosal and Systemic Immunity to Incorporated Antigens by Specific Targeting of B Cells

Published:2006-03-03 Issue:6 Volume:176 Page:3697-3706
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Helgeby Anja,Robson Neil C.,Donachie Anne M.,Beackock-Sharp Helen,Lövgren Karin,Schön Karin,Mowat Allan,Lycke Nils Y.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Modulation of immune responses following antigen administration by mucosal route

2. Mucosal Delivery of Vaccines

3. Oral tolerance

4. The liver: a model of organ-specific lymphocyte recruitment

5. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Markers of Early Immune Response in Tuberculosis: Prospects of Application in Predictive Medicine;International Journal of Molecular Sciences;2023-08-26

2. ISCOMs/MPLA‐Adjuvanted SDAD Protein Nanoparticles Induce Improved Mucosal Immune Responses and Cross‐Protection in Mice;Small;2023-05-10

3. Potentials of saponins-based adjuvants for nasal vaccines;Frontiers in Immunology;2023-03-20

4. Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines;Chemical and Pharmaceutical Bulletin;2022-05-01

5. Advancement in Nanomaterial Synthesis and its Biomedical Applications;Nanotechnology in the Life Sciences;2022